Avalon GloboCare Corporation (ALBT) Quote

ALBT.....Took some .53's today.

ALBT.....Going to buy the morning weakness

Wow! Congrats.
HOD 1.44

$ALBT

Is any catalyst or any news that is making it run like this ? Or just a group pushing it?
Thanks

WHAT A BEASTLY MOVE!!!!

ALBT: 600% on the way.

ALBT: The CLEVER traders have flipped this puppy TWO times today --- each time tossing circa 10-to-20 grand at it, just at the RIGHT time, then DUMPED for reasonable profits.

DILUTION....ONLY GROUP IS A ALGORITHM!!

No back to .30s

Clearly a group p&d …

ALBT: Whelp, now it looks like ALBT's --- shall we say --- "52-week HIGH"???

ALBT BLOWING UP

P&d

Yikes

Still shorting? ....Thanks!!!

Ez short

ALBT new 52 week low

ALBT new 52 week low

ALBT new 52 week low

Should be about ready

Loading...

ALBT.........................https://stockcharts.com/h-sc/ui?s=ALBT&p=W&b=5&g=0&id=p86431144783

$ALBT 2.08 ready to go!

Check out this report from WallstreetPR.

Why ALBT Merits Close Attention at Deep Discount Levels

AI is already having a major impact on the biotech industry, and its influence is only going to grow in the years to come.

One of the most promising applications of AI in biotech is the development of new drugs and therapies. AI can be used to screen vast libraries of compounds for potential drug candidates and to identify new targets for drug development. AI can also be used to design new drugs that are more likely to be effective and less likely to have side effects.

AI is also being used to improve the efficiency of manufacturing processes in the biotech industry. AI can be used to optimize the production of drugs and therapies and to identify potential problems in the manufacturing process. AI can also be used to automate tasks that are currently performed by humans, which can free up human workers to focus on more complex tasks.

Personalization is a big part of this equation. AI can be used to analyze a patient’s medical data and identify potential risks and vulnerabilities. AI can also be used to recommend personalized treatments for patients.

Overall, AI is being used to develop new drugs and therapies, improve the efficiency of manufacturing processes, and personalize healthcare in meaningful ways. And this has enormous implications for investors looking to position risk capital with a forward-looking mindset.

In other words, this is a breakthrough sub-industry in the making. And investors have yet to fully unearth all the gems emerging in this space.

With that in mind, we take a closer look today at one of the most interesting deep-discount names that fit this premise: Avalon GloboCare Corp. (NASDAQ: ALBT).

Read the full report here....
[/url]https://www.wallstreetpr.com/why-albt-merits-close-attention-at-deep-discount-levels-61133[url]

$ALBT This Biotech has a leading clinical diagnostics tech that could fast-track the company.

Avalon GloboCare Corp. (Nasdaq: ALBT) opened at $3.05 on 3/7/2023, with a weekly average price of $3.25 and its 20-day exponential moving average sitting at $3.71, 50-day moving average at $4.85, and 200-day moving average at $11.49. From here let’s calculate the upside potential if (ALBT) could reach those resistance levels.

First, if shares of (ALBT) were to reach its 20-day exponential moving average of $3.71, there would be a potential upside of 21.97% from the opening price of $3.05 on 3/7/2023.

If shares of (ALBT) were to reach its 50-day moving average of $4.85, there could be a potential upside of 59.02% from the 3/7/2023 opening price of $3.05.

Next, if shares of (ALBT) were to reach its 52-week high of $8.50, there would be a potential gain of 178.69% from the opening price of $3.05.

Then, if shares of (ALBT) were to reach its 200-day moving average of $11.49, there could be a potential upside of 277.70% from the opening price of $3.05.

Finally, if shares of (ALBT) were to reach its 2-year high of $16.50, there could be a potential upside of 440.98% from the opening price of $3.05 on 3/7/2023 and this would also be capping off a 689% move from the $2.09 52-week low put in on 3/3/2023, according to BarChart.com.

As mentioned above, none of these moves are certain. But, the potential needs to be noted.

Moreover, Avalon GloboCare Corp. (Nasdaq: ALBT) has less than 3.3 million shares available in its public float according to MarketWatch.com.

Low float stocks have the potential to present significant swings if active market participants take notice,(49) which could make (ALBT) an attractive watch target for those looking for companies with significant growth potential.

Overall, Avalon GloboCare Corp. (Nasdaq: ALBT) has several possible catalysts including its potential for growth and low public float, making it an attractive option for those looking to watch companies with significant potential.

Maybe that’s why Avalon GloboCare Corp. (Nasdaq: ALBT) insiders are holding onto so many shares according to Finviz.

Strong insider ownership can be an indication of a company’s health and long-term potential. When insiders own a significant percentage of a company’s shares, they have a vested interest in the company’s success, which can align their interests with those of other shareholders.

High insider ownership typically signals that insiders believe in the company’s future prospects and have confidence in its management team.

As of 3/7/2023, Finviz.com is reporting that insiders own over 33% of Avalon GloboCare Corp. (Nasdaq: ALBT), which could be a strong indication of confidence in the company’s future prospects.

This level of insider ownership could be a sign that the management team has a significant stake in the company’s success. When insiders own a large percentage of a company’s shares, it can also indicate that they are committed to the company for the long term, as they have a significant financial stake in its future performance.

The market often views high insider ownership as a positive signal, as it indicates that insiders are financially interested in the company’s success.

This can also provide shareholders with greater transparency into the company’s operations and decision-making processes, as insiders are more likely to share information with shareholders who have a vested interest in the company’s success.

Read the full report here.....

[url][tag]insert-text-here[/tag]https://biotechstockmarketnews.com/this-living-cure-targets-only-cancer-cells/?utm_source=wallstreetpr&utm_medium=affiliate&utm_campaign=albt&_ef_transaction_id=ff8fd205e7234143b056e5130c665ce3[url][tag]insert-text-here[/tag]

Adding here this week!

$ALBT

Very positive catalysts.

Mystery stock hopefully the earnings will show something good.

ALBT.............................https://stockcharts.com/h-sc/ui?s=ALBT&p=W&b=5&g=0&id=p86431144783

AVCO great looking volume!

Giant news today! Was loaded up in the .40s I knew something was up as the volume started to uptick.
New name and symbol change on November 10th, and trading on the new Nasdaq tier
https://finance.yahoo.com/news/avalon-globocare-signs-definitive-agreement-141000148.html

Check the news today, its giant. Name and ticker change on Thursday, private placement for $1.00 per share. Big things happening, glad I jumped back in the .40s
https://finance.yahoo.com/news/avalon-globocare-signs-definitive-agreement-141000148.html

The buy signal was 11/3 Glad I managed to get in 2 days earlier at .40
https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=AVCO

Picked up a good block at .40 as the stock is oversold. Was kind of amazed today with 0 news, and this was up 34% on high volume. Volume precedes price. Something could be brewing. Will see

Looks like basic consolidation is what I’m seeing. Nobody likes it on Fridays but that the way it is! Next week should be better yet

I couldn't agree more. I'm liking this and the way it's trading on a Friday afternoon bodes well for next week. A little bit in the red but not a massive drop.

$AVCO Like this a ton heading into next week..just a little more buying pressure sends this..

Solid start here.Looks good so far.

Looking to close the week out strong..

Add $AVCO as an undiscovered Biotech company…this one has all the makings of making some noise..chart has been green all week long and looking to pop .60

I agree. Really did well yesterday and I'm expecting a good run today as well. Did pretty good considering how light the volume was in the overall market yesterday.

$AVCO Biotech company that should be on everyone’s watchlist and in portfolios..website really opened my eyes..

avalon-globocare.com

$AVCO looks like it wants to gap over the 50 DMA this morning. Might make a run at the 200 DMA today as well https://schrts.co/EpVwsuiC

Starting to move nicely here with some strong volume stepping in.

Still green here and coming up off the low of day. Looks like she'll start moving higher in the coming hour or two.

Volume picks up any the next couple of hours this is going to fly. Looks very strong at open and just need some volume to come kicking in. I think this is about to blast off in my opinion.

$AVCO Some may be shocked at the strong move underway this week..but I’m not.. checkout this companies website and see why I’m very bullish on this company..and take note of the increase in buying volume.very telling..

avalon-globocare.com

$AVCO chart setting up beautifully here, next test will be the 50 DMA https://schrts.co/zNKbGteC

$AVCO Beautiful breakout just underway on the chart as MACD breaking positive..is history is any indication..could see a nice continuation from here..

https://stockcharts.com/c-sc/sc?s=AVCO&p=D&b=5&g=0&i=0&r=1666173165936

Up 7% on strong early volume. Probably within an hour or two will go over the 10-day average on volume and there's a lot of buying taking place here. Looks good.